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Abstract Stem cells are unique in that they possess both
the capacity to self-renew and thereby maintain their
original pool as well as the capacity to differentiate into
mature cells. In the past number of years, transcriptional
profiling of enriched stem cell populations has been
extensively performed in an attempt to identify a universal
stem cell gene expression signature. While stem-cell-
specific transcripts were identified in each case, this
approach has thus far been insufficient to identify a
universal group of core “stemness” genes ultimately
responsible for self-renewal and multipotency. Similarly,
in the hematopoietic system, comparisons of transcriptional
profiles between different hematopoietic cell stages have
had limited success in revealing core genes ultimately
responsible for the initiation of differentiation and lineage
specification. Here, we propose that the combined use of
transcriptional profiling and genetic linkage analysis, an
approach called “genetical genomics”, can be a valuable
tool to assist in the identification of genes and gene
networks that specify “stemness” and cell fate decisions.
We review past studies of hematopoietic cells that utilized
transcriptional profiling and/or genetic linkage analysis, and
discuss several potential future applications of genetical
genomics.
Keywords Hematopoieticstemcells.Cellfatedecisions.
Transcriptionalprofiling.Geneticlinkageanalysis.
Geneticalgenomics
Introduction
Stem cells are defined by their capacity to self-renew and
their ability to differentiate into mature cell types. Stem
cells can be divided into two main categories: embryonic
stem cells (ESCs) and “tissue-specific” stem cells. ESCs,
which are derived from the blastocyst stage of the early
embryo, are termed pluripotent because they are able to
differentiate into cells of all three germ layers; ectoderm,
endoderm, and mesoderm. In contrast, tissue-specific stem
cells are termed multipotent because they are only able to
differentiate into a limited number of more closely related
cell types. Tissue-specific stem cells have now been
identified in a number of fetal and adult tissues, where
they play essential roles in organogenesis, tissue homeo-
stasis, and repair.
One of the major challenges in the stem cell field has
been to identify a universal “stem cell signature”, that is,
those genes that ultimately enable the hallmark stem cell
features of self-renewal and pluripotency or multipotency.
In addition, it is important to identify those genes that
initiate differentiation and determine lineage specification.
In this review, we discuss how these challenges might be
addressed using the combinatorial approach of genetical
genomics. In particular, we focus on hematopoietic stem
cells (HSCs), one of the best studied stem cell systems, as a
model to investigate cell fate decisions.
HSCs are rare cells in the bone marrow that both self-
renew and generate differentiated blood cells. During the
process of hematopoietic differentiation, the cells progres-
sively amplify their numbers, lose their multipotency and
become increasingly committed. Ultimately, HSCs are able
to give rise to large numbers of cells of both myeloid (e.g.
macrophages, granulocytes, erythrocytes, and megakaryo-
cytes/platelets) and lymphoid lineages (e.g. T-cells and
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hematopoiesis is depicted in Fig. 1. Although HSCs,
intermediate progenitors, and most mature blood cells are
genetically identical and are only a few cell divisions apart
from each other, they differ tremendously in both pheno-
type and function.
In search of a stem cell signature
Since HSCs share certain hallmark properties with other
stem cell types, it was speculated that a universal stem cell
signature, consisting of a common set of genes whose
concerted expression grant stem cells their unique proper-
ties, might exist. In an attempt to identify such a signature,
the expression profiles of mouse ESCs, HSCs, and neural
stem cells (NSCs) were compared by two groups indepen-
dently (Ivanova et al. 2002; Ramalho-Santos et al. 2002).
Both studies revealed similarities and differences between
these cell populations, and generated a list of over 200
stem-cell-specific genes that mouse ESCs, HSCs and NSCs
commonly expressed. Strikingly however, these two lists
shared only six genes. Soon thereafter, a third independent
expression profiling study comparing ESCs, NSCs, and
retinal progenitor/stem cells was reported. Comparing these
three independently generated lists of “stemness” genes,
only one gene (Itga-6) was commonly identified (Fortunel
et al. 2003). What could explain the lack of overlap
between these lists? First, differences in methodology
may be in part responsible (discussed in Burns and Zon
2002; Evsikov and Solter 2003). Second, ESCs are
pluripotent, while the other stem cell types in the described
comparisons are more restricted in their developmental
potential. These different stem cell populations were
compared in a direct manner, although it is certainly
possible that pluripotency and multipotency are maintained
by different gene circuits. A third, more fundamental
possibility is that a universal stem cell signature simply
does not exist. ESCs, HSCs, NSCs, and retinal stem cells
may each have their very own transcriptional networks
responsible for their unique stem cell properties. If this is
the case, cross-tissue comparative stem cell transcriptome
analyses are not particularly useful approaches to identify
these stem cell type-specific signatures.
That a limited number of factors could indeed specify
“stemness” was convincingly shown by Takahashi and
Yamanaka (2006), who demonstrated that the forced
expression of Oct4, Sox2, Klf4 and c-Myc and could
reprogram mouse fibroblasts into pluripotent stem cells that
were functionally equivalent to ESCs. Subsequently, it was
shown that some family proteins of the four factors could
also reprogram fibroblasts, and that c-Myc was dispensable
for this process (Nakagawa et al. 2008; Wernig et al. 2008).
The question whether terminally differentiated cells could
also be reprogrammed was resolved when fully differen-
tiated mature mouse B lymphocytes were reprogrammed to
pluripotency (Hanna et al. 2008). Induction of pluripotency
was also recently demonstrated in human fibroblasts using
various combinations of factors (Park et al. 2008; Takahashi
et al. 2007; Yu et al. 2007). The demonstration that more
than one combination of factors could confer the same stem
cell characteristics suggests that stem cell signatures may be
“degenerate” (as in the “degenerate DNA code”).
Thus, it is clear that “stemness” can be achieved by only
a limited number of key stem cell regulators, presumably
targeting larger collections of downstream genes in a
hierarchical manner. Extracting such key regulators (or
causes) from their downstream target genes (consequences)
is not feasible using microarray profiling approaches alone.
In search of hematopoietic fate determinants
Transcriptional profiling has also been utilized extensively
in an attempt to identify genes whose expression distin-
guishes HSCs from their downstream progeny. Global
expression analyses have revealed that stem cells exist in
a “promiscuous” state where multiple lineage-specific
genes are coexpressed, albeit at very low levels. Upon
differentiation, “appropriate” lineage-specific genes are up-
regulated, whereas “inappropriate” genes, specific for other
lineages, are down-regulated (Enver and Greaves 1998).
Recently, Chambers et al. generated an expression database
of various hematopoietic cell types, including HSCs,
erythroid cells, granulocytes, monocytes, natural killer
cells, activated and naive T cells, and B cells (Chambers
Fig. 1 Simplified overview of hematopoiesis. Hematopoietic stem
cells (HSCs) have self-renewal activity (represented as the arrow) and
can therefore maintain their numbers. During hematopoietic differen-
tiation, HSCs lose their self-renewal capacity and become increasingly
lineage-committed (represented as the gradual loss of colors)
412 Immunogenetics (2008) 60:411–422et al. 2007a). This comparative transcriptome analysis
provided large lists of genes that are specifically expressed
in one cell stage or cell type compared to another. However,
it is improbable that the transition from one cell stage to
another relies on the independent regulation of so many
genes. More likely, activation of a limited number of key
regulatory genes initiates a cascade of events, resulting in
the altered expression of tens to hundreds of genes.
Transcriptional profiling has proven to be a useful
approach to identify cell stage and cell type-specific tran-
scripts. When combined with other genetic approaches, it
may also have the potential to identify key regulatory genes.
HSCs and linkage genetics
It has become clear that many hematopoietic characteristics
or traits are genetically controlled, since they differ between
various strains of genetically distinct laboratory mice. For
example, a substantial strain-to-strain variation in the
number of primitive hematopoietic cells and their turnover
rates has been observed. Interestingly, an inverse correla-
tion was detected between progenitor cell turnover rate and
mouse lifespan (De Haan et al. 1997).
Two regular inbred strains of mice, C57BL/6 (B6) and
DBA/2 (D2), have distinct differences in both their HSC
traits and lifespan. Compared to B6 mice, D2 mice have a
shorter lifespan, a substantially higher HSC frequency, and
their progenitors cycle at a much faster rate (De Haan et al.
1997; De Haan and Van Zant 1997; Muller-Sieburg and
Riblet 1996; Van Zant et al. 1983). In B6 mice the HSC
frequency increases at a constant rate during the aging
process (Harrison et al. 1989; Liang et al. 2005; Morrison et
al. 1996; Sudo et al. 2000), while in D2 mice it increases up
to one year of age and then drops again (Chen et al. 2000;
De Haan and Van Zant 1999a). The observed natural
variation between these regular inbred mouse strains offers
a powerful tool to study the genetic basis of variation in
these traits. The use of B6 x D2 (BXD) recombinant inbred
mouse strains has been a particularly useful strategy to
identify genomic regions affecting traits of interest. These
inbred lines were developed by crossing the two inbred
parental strains followed by repeated sibling–sibling mating
for a minimum of 20 generations. The resulting BXD
mouse strains each carry a genome that consists of a unique
mosaic of homozygous B6 and D2 segments. At present,
the BXD panel is composed of 80 different strains that all
have been fully genotyped (Peirce et al. 2004). Variation in
any quantifiable trait can be associated with the segregation
of parental alleles, and linkage genetics can map this
variation to quantitative trait loci (QTLs), thereby identify-
ing the genomic region(s) affecting that trait. An overview
of the QTL mapping approach is depicted in Fig. 2.
Classical QTL analysis has permitted the identification of
loci that are associated with variation in HSC traits. When
HSC frequency was measured in the BXD reference panel
using long-term culture initiating cell assays (LTC-ICs), two
suggestive QTLs on chromosome 1 and one on chromosome
11 were identified. One of the loci on chromosome 1 was
confirmed to affect HSC frequency in a congenic mouse
strain (Muller-Sieburg and Riblet 1996). When HSC
frequency was assessed using cobblestone area forming
cell assays, the trait mapped to a region on chromosome 18
(De Haan and Van Zant 1997). Subsequently, variation in
Fig. 2 Overview of (expression) quantitive trait locus mapping
procedure. Variation in phenotype (here shown for six individuals) is
correlated with variation in genotype (genotypes at a single chromo-
some are shown for each individual). The genomic location where
these two parameters associate most strongly is referred to as the
(expression) quantitative trait locus or (e)QTL. In this case, the three
genetically distinct individuals that have a high value for the
phenotype of interest carry the light blue genotype at the (e)QTL
position, whereas the three that have a low phenotypic measure carry
the dark blue genotype at that position. The phenotype can either be a
classical trait (classical linkage) or the expression level of a gene
(genetical genomics)
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frequency were mapped in both young and old mice. This
led to the identification of multiple QTLs, some of which
were age- and differentiation stage-specific. Regardless of
age, loci on chromosomes 7 and 18 were found to regulate
HPC and HSC frequency, respectively. An additional locus
on chromosome 1 was found to affect HPC and HSC
frequency specifically in young mice, whereas loci on
chromosomes 2 and 18 were found to affect these
frequencies specifically in old mice (Geiger et al. 2001).
A congenic mouse model was later used to confirm that the
chromosome 2 locus indeed contained a regulator of HSC
aging (Geiger et al. 2005). Variation in the percentage
change of HSC frequency during aging was mapped to
putative loci on chromosomes 2, 14, and X (De Haan and
Van Zant 1999a).
Particularly interesting was the finding that variation in
both turnover rate of primitive hematopoietic cells and
mouse lifespan mapped to overlapping regions on chromo-
somes 7 and 11 (De Haan and Van Zant 1999b). This
strengthened the hypothesis that mouse lifespan is in part
dependent on progenitor turnover rate.
Yet another trait in which various inbred strains of mice
have shown to differ is their absolute number of Lin
−Sca-1
++
cells and their responsiveness to early-acting cytokines such
as kit ligand, flt3 ligand, and thrombopoietin. A genetic
linkage study in BXD recombinant inbreds led to the
identification of three loci on chromosomes 2, 4, and 7 that
affected the total number of Lin
−Sca-1
++ cells and a locus
on chromosome 2 affecting their proliferative response to
cytokines. The fact that both traits mapped to the exact
same region on chromosome 2 suggests that the number of
Lin
−Sca-1
++ cells may depend on their responsiveness to
cytokines (Henckaerts et al. 2002). This hypothesis was
reinforced when a QTL for the response of primitive cells
to transforming growth factor-β2 (TGF-β2) was identified
on chromosome 4 that overlapped with the previously
identified QTL regulating the number of Lin
−Sca-1
++ cells
(Langer et al. 2004).
Furthermore, a strain-dependent variation was found to
exist in the response to Granulocyte Colony-Stimulating
factor (G-CSF); a growth factor that has the capacity to
mobilize stem and progenitor cells from bone marrow into
peripheral blood (Roberts et al. 1997). When B6 (low
responder), D2 (high responder), backcross, and BXD mice
were subjected to a genetic analysis, loci on chromosomes
2 and 11 (and possibly 4 and 14) were found to control G-
CSF induced mobilization (Hasegawa et al. 2000).
An overview of the QTLs that have been reported to
associate with various hematopoietic traits is shown in
Table 1. Interestingly, multiple traits have been mapped to
the same QTL regions (note the “QTL-dense” regions on
chromosomes 2 and 11), suggesting that they may be
regulated by a common genetic element. It should also be
noted that only a few QTLs have been independently
replicated. In part, this is because relatively few laboratories
have used quantitative trait genetics to study hematopoiesis.
Secondly, it may be due to the inherently noisy quantitative
nature of the traits under study as they are likely to be
controlled by multiple QTLs that each have a limited effect.
Finally, multiple in vitro and in vivo assays exist that
measure the functional output of primitive hematopoietic
cells. Although these assays are thought to have consider-
able overlap with each other, they may not be measuring
exactly the same spectrum of cells. Thus, it is possible that
these distinct cell subsets are controlled by different genetic
elements.
The major limitation of classical QTL mapping
approaches in recombinant inbred reference panels is that
they are only able to identify genomic regions of interest,
usually containing tens or even hundreds of genes. This
poor resolution is due to the limited number of recombina-
tion events between the two sets of parental chromosomes.
Of all the genes present within the QTL interval, it is
hypothesized that only polymorphic variants can be
responsible for variation in the observed phenotype. In
most cases, this variability is in the form of single
nucleotide polymorphisms (SNPs), and to a lesser extent
in the form of deletions, insertions, rearrangements, and
copy number variations. Although every SNP has a
potential impact on gene expression levels and therefore
could affect HSC biology, the vast majority of SNPs are
“synonymous” or “silent” (Kimura 1968; King and Jukes
1969). This makes it difficult to identify the causal variant
or polymorphism, and therefore the causal gene that
influences the trait of interest. An additional complication
is the possibility that multiple linked (possibly even
neighbouring) genes collectively cause the phenotype, as
was proposed for the progenitor cell cycling trait (De Haan
et al. 2002). A promising approach that may aid in the
identification of causal genes—and the networks in which
they operate—is the combination of transcriptional profil-
ing with linkage genetics.
Transcriptional profiling and linkage genetics combined
As explained, neither transcriptional profiling alone, nor
genetic linkage analysis alone, has been shown to be an
effective approach to identify genes or gene networks that
specify “stemness”, initiate differentiation or govern lineage
specification. However, the combination of both
approaches may aid in their identification. Merging the
fields of linkage genetics and genomics in this particular
manner has been referred to as “genetical genomics”
(Jansen and Nap 2001) or expression quantitative trait
414 Immunogenetics (2008) 60:411–422Table 1 Quantitative trait loci (QTLs) associated with mouse hematopoietic traits
Trait Chr Region (cM) Reference
HPC frequency 1 38 Geiger et al. 2001
HSC frequency 1 38 Geiger et al. 2001
HSC frequency (LTC-IC) 1 52 Muller-Sieburg and Riblet 1996
Splenomegaly after G-CSF 1 53–75 Roberts et al. 2000
HSC frequency (LTC-IC) 1 99 Muller-Sieburg and Riblet 1996
HSC frequency 1 100 Geiger et al. 2001
Change in HSC frequency during aging 2 51 De Haan and Van Zant 1999a
Lifespan 2 69 De Haan and Van Zant 1999b
Progenitor cell mobilization by G-CSF 2 69? Hasegawa et al. 2000
HPC frequency (old) 2 72 Geiger et al. 2001
HSC frequency (old) 2 72 Geiger et al. 2001
No. Lin
−Sca-1
++ cells 2 73.2–77.2 Henckaerts et al. 2002
Response of primitive cells to cytokines 2 73.2–77.2 Henckaerts et al. 2002
HSC frequency 3 24 Geiger et al. 2001
Lifespan 4 40.3 De Haan and Van Zant 1999b
Response of primitive cells to TGF-β24 6 7 –79 Langer et al. 2004
No. Lin
−Sca-1
++ cells 4 77.5–79 Henckaerts et al. 2002
Progenitor cell cycling 4 78 De Haan and Van Zant 1999b
Progenitor cell mobilization by G-CSF 4 ? Hasegawa et al. 2000
HSC frequency 5 20 Geiger et al. 2001
Progenitor cell cycling 7 0.5 De Haan et al. 2002
Progenitor cell cycling 7 6 De Haan and Van Zant 1999b
Lifespan 7 6 De Haan and Van Zant 1999b
HPC frequency 7 8 Geiger et al. 2001
HPC frequency 7 25 Geiger et al. 2001
HPC frequency 7 50 Geiger et al. 2001
HPC frequency (old) 7 50 Geiger et al. 2001
No. Lin
−Sca-1
++ cells 7 51–53 Henckaerts et al. 2002
Progenitor cell cycling 9 61 De Haan and Van Zant 1999b
Progenitor cell mobilization by G-CSF 11 3 Hasegawa et al. 2000
Progenitor cell cycling 11 29 De Haan et al. 2002
Progenitor cell cycling 11 31 De Haan and Van Zant 1999b
Lifespan 11 31 De Haan and Van Zant 1999b
HSC frequency (LTC-IC) 11 32 Muller-Sieburg and Riblet 1996
Change in HSC frequency during aging 14 12 De Haan and Van Zant 1999a
HPC frequency (old) 14 13 Geiger et al. 2001
Progenitor cell mobilization by G-CSF 14 ? Hasegawa et al. 2000
HSC frequency 15 43 De Haan and Van Zant 1997
HPC frequency (old) 15 59 Geiger et al. 2001
HSC frequency 18 19 De Haan and Van Zant 1997
HSC frequency 18 27 Geiger et al. 2001
HPC frequency (old) 18 27 Geiger et al. 2001
HSC frequency (old) 18 27 Geiger et al. 2001
Change in HSC frequency during aging X 5 De Haan and Van Zant 1999a
HSC frequency X 51 Geiger et al. 2001
Response of primitive cells to cytokines X ? Henckaerts et al. 2002
All traits were studied in C57Bl/6, DBA/2, backcross and/or BXD recombinant inbred mice. Unless noted otherwise, traits were analyzed in
young mice, and HPC and HSC frequencies were measured using CAFC assays. Italic font indicates traits and corresponding QTLs that are
mentioned elsewhere in this review. Entries in bold indicate “QTL-dense” regions. (Note that not all of the reported genetic associations have met
the most stringent statistical threshold for significant genome-wide linkage. Also note that in the past decade, the mouse genome map has
undergone significant revisions, and therfore the precise genomic locations of the identified QTLs may be slightly inacurate, especially in older
publications. Nevertheless, for historical accuracy, this table shows QTL regions as specified in the original references.)
Abbreviations: CAFC Cobblestone area forming cell, G-CSF granulocyte colony-stimulating factor, HPC hematopoietic progenitor cell, HSC
hematopoietic stem cell, LTC-IC long-term culture-initiating cell, TGF transforming growth factor, ? exact region not specified
Immunogenetics (2008) 60:411–422 415locus (eQTL) analysis (Schadt et al. 2003, 2005). The
genetical genomics approach considers individual gene
expression levels to be quantitative traits. In cell types
isolated from genetically distinct individuals (e.g. BXD
recombinant inbred mouse strains), linkage mapping can
then be utilized to identify genomic regions affecting each
gene expression trait (eQTL). The strategy of eQTL
mapping is visualized in Fig. 2. Hence, genetical genomics
studies the genetic basis of variation in gene expression.
When the genomic position of the gene and the eQTL
which is associated with variation in its expression level
coincide, the gene is considered to be cis-regulated. In
contrast, when the eQTL associated with variation in its
expression level maps to another position in the genome,
the gene is considered to be trans-regulated. Cis-regulation
is thought to arise from either local polymorphisms in the
regulatory elements that alter gene expression levels, or
alternatively to arise from polymorphisms in the coding
region that affect mRNA stability or feedback regulation
(Fig. 3a). Cis-regulation can also originate from copy-
number variability. Trans-regulation is thought to arise as a
result of polymorphisms in the regulatory elements or
coding region of a direct or indirect upstream regulator
(Fig. 3b). It should be emphasized that in this review the
terms cis-a n dtrans-regulation do not refer to the
underlying molecular nature of the regulation, but only to
the distance between the physical genomic position of a
gene and its corresponding eQTL position. For this reason,
it is possible that a gene can be classified as cis-regulated,
even though it is actually regulated by one of its
neighbouring genes. To reduce the potential confusion
between the type of regulation and the relative positions
of genes and their eQTLs, the terms “local” and “distant”
have also been proposed (Rockman and Kruglyak 2006).
Brem et al. (2002) were the first to report genetic
mapping of global gene expression in a yeast cross. Since
then, genetical genomics has been applied to genetically
distinct strains of Arabidopsis thaliana, Eucalyptus, maize,
Caenorhabditis elegans, mice, rats (Bystrykh et al. 2005;
Chesler et al. 2005; DeCook et al. 2006; Hubner et al.
2005; Kirst et al. 2004; Li et al. 2006; Schadt et al. 2003),
and also to cells isolated from human individuals (Monks et
al. 2004; Morley et al. 2004). Collectively, these studies
convincingly demonstrate the heritability of variation in
transcript abundance and the presence of both cis- and
trans-regulated genes. In addition, it is clear that the
genetical genomics approach is broadly applicable to
multiple species and cell types. A representative example
of a genome-wide overview of genes and their eQTLs is
depicted in Fig. 3c. This eQTL regulator map was created
by plotting the physical genomic position of variably
expressed genes and the genomic positions that were most
strongly associated with variation in their expression levels
(eQTLs). Transcripts on the diagonal represent cis-regulated
genes. Collections of transcripts that are identified as
vertical bands or “transbands” represent genes that are
located throughout the whole genome, but are thought to
be transcriptionally affected by a common eQTL. If a
certain genomic region harbors a higher frequency of
eQTLs than expected by chance, it is termed an eQTL
hotspot (Brem et al. 2002; Schadt et al. 2003). The causal
regulator within such an eQTL interval may be a signalling
or transcription factor that affects the expression levels of
its downstream targets.
Associated with each eQTL are two important sets of
genes: those regulated by the eQTL (transband genes if
more than one) and those within the eQTL interval that are
candidate regulators. These regulators can either directly or
indirectly affect the abundance of the transband transcripts,
raising the prospect of several levels of hierarchy within the
regulatory network (Fig. 3d).
To identify the causal gene within each eQTL, the
interval is first screened for genetic variability, since only
those genes that are polymorphic can have a functional
impact on the transcript abundance of the transband genes.
Both regulatory elements and coding regions must be
analyzed for the presence of polymorphisms. In particular,
cis-acting genes are high-priority candidate regulators, as
they may contain genetic variants that not only influence
their own expression levels, but also those of the transband
genes. Another category of genes which could affect the
expression of the transband genes are those that are equally
expressed, but carry polymorphisms in their coding regions,
resulting in the generation of functionally distinct proteins
with a differential ability to regulate downstream targets.
For example, these polymorphisms can alter protein
functionality by being “nonsynonymous” (amino acid
changing) or alternatively by introducing alternative splic-
ing. It should be noted that this category of candidate
regulators would remain unnoticed in traditional microarray
experiments, since the expression levels of such transcripts
would not necessarily be altered.
While it is tempting to assume that trans-regulated genes
preferentially map to eQTL intervals containing transcrip-
tion factors, in yeast this could not be verified (Yvert et al.
2003). Another potential category of regulatory genes
consists of signalling factors that can indirectly affect the
abundance of the transband transcripts.
Although the terms cis- and trans-regulation are com-
monly accepted descriptions of gene regulatory relation-
ships, their biological relevance is only assumed. While it is
clear that genetical genomics has great potential to identify
novel regulatory pathways and increase our understanding
of regulatory networks, functional validation of candidate
regulators is ultimately necessary to confirm their biological
activity.
416 Immunogenetics (2008) 60:411–422HSCs and genetical genomics
Classical QTL mapping results in the identification of
genomic intervals that affect traits of interest. This approach
narrows down the number of candidate genes affecting such
traits from around 30,000 (all genes in the genome) to tens
or hundreds of genes (those located within that QTL
interval). However, despite this major improvement, for a
molecular biologist it would still require a huge effort to
functionally test all the candidate genes in that interval.
A complementary approach to assist in the identifi-
cation of candidate genes affecting stem cell traits is
genetical genomics. Using the Affymetrix gene expres-
sion platform we collected data for each of the inbred
strains from the BXD reference panel and the variation
in transcript abundance in primitive Lin
−Sca-1
+c-Kit
+
cells of each gene was mapped to an eQTL. Using
stringent significance thresholds, a total of 162 cis-
regulated and 136 trans-regulated genes were identified.
Runx1, a well-known hematopoietic regulator (Okuda et
al. 1996;W a n ge ta l .1996), was found to be strongly cis-
regulated. Interestingly, two of its known downstream
targets (Tcrb and Csf1r) were found to be coregulated
with Runx1, indicating the biological relevance of the
networks that could be identified. The generation of this
comprehensive eQTL dataset allowed the more detailed
analysis of QTL intervals that had previously been
identified using the classical approach. Cis-regulated
genes within these intervals represent the best candidate
regulators, as they may harbor genetic variants that
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Fig. 3 Cis- and trans-regulated gene expression. Cis-regulation is
expected to originate from polymorphisms (red triangles) in the
regulatory elements (white circles) or the coding region (colored
rectangle) of the gene itself (or possibly of a nearby gene) (a). Trans-
regulation is expected to originate from polymorphisms in the
regulatory elements or the coding region of a gene located distant
from the gene whose expression it controls. Note that variation in
expression of multiple genes can map to the same gene in trans (b).
Transcripts and their eQTLs are graphically depicted in a genome-
wide eQTL regulator map. Plotted on the y-axis are the physical
positions of all measured transcripts, whereas on the x-axis the
genomic regions that are most strongly associated with variation in
expression levels (i.e. eQTLs) of the corresponding transcripts are
shown. When transcript and eQTL position coincide, the transcript is
considered to be cis-regulated and plotted on the diagonal. The
vertical transband refers to transcripts encoded by genes that are
positioned throughout the whole genome, but map to the same eQTL
position. Transband transcripts are suggested to be coregulated.
Potential transband regulators are located within the eQTL interval
(where the transband meets the x-axis). Figure adapted from Bystrykh
et al. 2005 (c). Coregulated transband genes can be directly or
indirectly targeted by the potential regulator, thereby creating a
network that consists of multiple levels of gene regulation (d)
Immunogenetics (2008) 60:411–422 417affect both their own expression levels and the trait of
interest. Within the QTL interval on chromosome 11 to
which we had previously mapped a region associated
with hematopoietic progenitor cell turnover, only eight
cis-regulated genes were identified, thereby reducing the
number of candidate genes for functional testing
(Bystrykh et al. 2005).
An example of the power of this combined approach
was recently provided by Liang et al. Classical QTL
analysis had previously identified regions on chromo-
somes 3, 5, and 18 that associated with variation in HSC
frequency (Geiger et al. 2001). Using reciprocal congenic
mouse strains, the chromosome 3 QTL interval in isolation
was subsequently shown to be sufficient to confer this stem
cell phenotype. Thereafter, a detailed analysis of differen-
tially expressed transcripts within the QTL interval,
followed by functional confirmation, led to the identifica-
tion of Lxn as a gene involved in determining HSC
frequency (Liang et al. 2007).
It should be noted that large collections of expression
data have been deposited in the online database
GeneNetwork (http://www.genenetwork.org) and are free-
ly accessible to the research community (Chesler et al.
2004). GeneNetwork contains genotypic, phenotypic, and
gene expression data from several species, including
Arabidopsis thaliana, barley, mouse, and rat. Within the
mouse BXD reference population, expression data of
multiple tissues (HSCs, regulatory T cells, various neural
tissues, eye, liver, lung, and kidney) are present, which
permit the distinction between genes that are expressed or
regulated in a tissue-specific manner from those that are
equally expressed or regulated in multiple tissues.
Multidimensional genetical genomics
Genetical genomics has proven to be a valuable tool for the
identification of genes and gene networks that operate in
HSCs. Yet, its potential impact is only emerging and has
not been fully exploited. Therefore, in this section we will
address the future applications of genetical genomics.
Adding the dimension of closely related cell types
Genetical genomics has primarily been limited to single cell
types. A more powerful approach would be to apply the
same approach to closely related cell types. This would
allow comparative analyses of gene regulatory networks
between distinct but related cells. In the HSC field such
multidimensional genetical genomics studies have not yet
been performed. However, Li et al. (2006) recently
demonstrated the general validity of the approach through
the application of genetical genomics to Caenorhabditis
elegans recombinant inbred strains that were exposed to
different temperatures. Their results showed heritable
variation in gene expression responses to these environ-
mental changes. This has created a solid basis for future
multidimensional genetical genomics approaches.
In the hematopoietic system, genetical genomics
could conceivably be applied to different hematopoietic
cell stages (e.g. primitive HSCs, committed progenitors,
and fully differentiated blood cells). Inclusion of this
additional dimension would enable the study of cell fate
decisions during the process of hematopoietic cell
differentiation. Whereas classical analysis of gene
expression levels during differentiation evaluates the
dynamics of gene expression, analyzing eQTLs during
differentiation evaluates the dynamics of gene regulation,
permitting the identification of genes and gene networks
that are specifically active in one cell type and not in
another. Although eQTL profiles of different species
and different cell types within the same species have
previously been compared, eQTL profiles have never
been evaluated for highly purified cell types that are so
closely related. By implementing a “subtractive geneti-
cal genomics approach” a distinction can possibly be
made between common or “housekeeping” eQTLs and
those eQTLs that are specific for only one cell stage.
Multidimensional genetical genomics would also be a
powerful tool to study age-dependent changes in the HSC
compartment. Previous studies have compared the tran-
scriptional profiles of HSC-enriched populations from
young and old murine bone marrow. The collections of
genes reported to be up-regulated in aged stem cells
included those involved in inflammatory and stress
responses (Chambers et al. 2007b) and signal transducer
activity and receptor activity (Rossi et al. 2005), whereas
those down-regulated during aging were genes involved in
DNA repair and chromatin remodelling (Chambers et al.
2007b). While these studies revealed thousands of age-
regulated genes, the ultimate causes of these expression
perturbations remain unknown. Analyzing age-dependent
gene expression changes using multidimensional genetical
genomics could bring the identification of genes causing
the age-induced alterations—and thereby future therapeutic
intervention strategies—one step closer.
Adding the dimension of epigenetics
Epigenetic gene regulation has been suggested to play a key
role in modulating stem cell fate. Epigenetics refers to
heritable gene expression changes that occur without DNA
sequence alterations, and includes DNA methylation and
histone modifications such as acetylation, methylation, and
ubiquitylation. These modifications can result in either gene
activation or gene repression. That epigenetic gene repres-
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ness” became apparent when a number of developmental
regulators were found to be epigenetically silenced in
murine ESCs and activated upon induction of ESC
differentiation (Bernstein et al. 2006; Boyer et al. 2006).
It is exciting to postulate that epigenetic modifiers might
similarly define cellular fate and lineage commitment
during hematopoiesis.
Since a differential epigenetic conformation of the
genome can result in variation in gene expression levels
that can in turn affect stem cell traits, it is possible that
such differential epigenetic states underlie some of the
observed (e)QTL effects. At this time, however, there is
insufficient knowledge on how epigenetic modifications
correlate with variation in gene expression levels on a
genome-wide scale. To this end, a powerful approach
would be to combine traditional transcriptome profiling
with whole-genome tiling arrays measuring chromatin-
immunoprecipitation and DNA methylation. If these
complementary array-based analyses were carried out
in the same reference panel of genetically distinct
individuals, not only variation in transcript abundance,
but potentially also variation in epigenetic conforma-
tions could be mapped to genomic loci. In this manner,
both the genetics of gene expression (i.e. “regular”
genetical genomics) and the genetics of epigenetics
could be studied simultaneously, thus revealing genes
that directly or indirectly affect epigenetic gene states.
An additional issue that could be addressed by such an
approach is to estimate the percentage of variation in
gene expression that can be explained by different
epigenetic conformations.
The level of complexity could be further increased by
including different cell types in the analysis, such as the
above-mentioned different hematopoietic cell stages, dif-
ferent stem cell types, stem cells derived from different
species, or stem cells of different ages. Through a
“subtractive QTL analysis” approach, cell type specific
QTLs that affect transcript abundance and/or epigenetic
gene states might thus be identified. The emergence of such
comparative analyses in the coming years will further the
understanding of regulatory networks and how they affect
cellular fate.
Adding the dimension of miRNAs
It is possible that some of the upstream regulators located
within (e)QTL intervals are in fact not protein-encoding
genes, but rather miRNAs. MiRNAs are small noncoding
RNAs complementary to one or often multiple mRNAs,
and their main function appears to be down-regulation of
gene expression. Certain miRNAs have been shown to be
differentially expressed between various hematopoietic cell
types, suggesting that they could be involved in lineage
specification (Chen et al. 2004). Polymorphisms in miRNA
production sites can alter their specificity, whereas poly-
morphisms in regulatory elements can alter their expression
levels. In addition, polymorphisms in miRNA target sites
can affect the binding of a miRNA and therefore their
capability to silence target gene expression. Any of these
miRNA sequence variants might underlie (e)QTL effects.
For example, polymorphic miRNA target sites located
within a gene (often in the 3’ untranslated region) might
underlie a cis-acting eQTL effect. Further, transbands could
be explained by a polymorphic miRNA production site that
is positioned within an eQTL interval, giving rise to a
miRNA that may differentially affect the expression levels
of its target genes.
Efforts have already been made to overlap poly-
morphic miRNA target sites with eQTL intervals and
known classical QTL intervals in an attempt to identify
miRNAs that not only underlie variation in gene
expression levels but also variation in cell biological
traits. Genes positioned in (e)QTL intervals can be
screened for polymorphisms in miRNA target sites in an
online database at http://compbio.utmem.edu/miRSNP/
(Bao et al. 2007).
Little is known about the factors that regulate the
expression levels of the miRNAs themselves. Genome-
wide miRNA profiling of cells isolated from genetically
distinct individuals would assist in this regard, since
through the use of genetic linkage, variation in miRNA
expression levels can be mapped to genomic regions
affecting miRNA expression levels.
Adding the dimension of clinical data
The sequencing of the human genome and the development
of transcriptome profiling technology have permitted new
approaches to characterize hematologic malignancies at the
molecular level. Gene expression profiles have been
generated for malignancies such as diffuse large B-cell
lymphoma, mantle cell lymphoma, acute myeloid leukemia,
acute lymphoblastic leukemia, chronic lymphocytic leuke-
mia, and multiple myeloma. All these malignancies could
be classified into molecularly distinct subgroups on the
basis of similarities in their gene expression profiles, and
genes whose expression could discriminate between these
distinct subgroups were identified (reviewed in Margalit et
al. 2005). Although this subgroup classification has
diagnostic, prognostic and therapeutic consequences, the
disease-initiating or causative factors are still not known. If
large scale clinical data and gene expression profiles were
combined with detailed genotypes of the patients, this
would permit the use of genetical genomics and therefore
the identification of QTLs that underlie complex diseases,
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works and biological processes are involved in both normal
and malignant hematopoietic cell development.
That genetical genomics could be applicable to human
data was demonstrated in two independent studies using
previously genotyped lymphoblastoid cell lines from
related individuals (Monks et al. 2004; Morley et al.
2004). In both studies the heritability of gene expression
levels was shown and eQTLs were identified, but there
were too many differences between the two approaches to
compare them in a direct manner (De Koning and Haley
2005). Association-based studies were also performed
using lymphoblastoid cell lines from unrelated individuals
(Cheung et al. 2005; Stranger et al. 2005). While these
studies demonstrated the potential of performing genetical
genomics using human data, the clinical relevance of these
approaches was limited since the studies were performed on
transformed human cell lines, were limited in their samples
sizes, and did not include any clinical phenotypes.
A more direct example of the clinical relevance of this
approach was recently provided by Goring et al. (2007),
who generated genome-wide transcriptional profiles of
normal untransformed lymphocytes from a large collection
of genotyped individuals whose plasma cholesterol con-
centrations were also measured. Using a genetical genomics
approach, VNN1 was identified as a gene affecting high-
density lipoprotein cholesterol concentrations.
In a second clinically relevant example, blood and
adipose tissues were collected from a large group of
subjects, after which genotypes, gene expression levels
and clinical traits related to obesity were analyzed in a
combinatorial fashion. A substantial correlation was found
between gene expression profiles of adipose tissue and
obesity-related traits, but not between blood expression
profiles and those traits. Importantly, genes and gene
networks that were enriched in inflammatory and immune
response pathways were identified that in part contribute to
obesity in humans (Emilsson et al. 2008). These examples
demonstrate how a multidimensional genetical genomics
approach can aid in the understanding of human health.
Closing remarks
In this review, we describe how transcriptional profiling has
helped to define the molecular identity of HSCs and other
cell types, and how the use of linkage genetics has
permitted the identification of specific genomic regions
that affect HSC traits. In particular, we focus on the
“genetical genomics” approach of combining transcription-
al profiling with genetic linkage analysis, and discuss the
potential added value of including additional dimensions in
the analysis. All approaches are summarized in Fig. 4.I n
the coming years, multidimensional genetical genomics
has the potential to greatly aid in revealing regulatory
networks that specify cell fate decisions not only in HSCs,
but in a whole range of clinically relevant cell types.
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Fig. 4 An overview of the
described approaches (left), the
sources of analysis (middle) and
the phenotypic measures (right)
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